Overview
This one hour program will feature 3 presentations and provide ample time for questions and discussion. This webinar will discuss the global impact of lung cancer on women and the changing landscape from past, current, and future. Recent analysis from multiple large lung cancer screening trials confirm the objective curative benefit of lung cancer screening and results suggest this benefit is considerately greater in women; the magnitude of these favorable outcomes far exceed the mortality benefit previously reported with breast or colon cancer screening. Low dose CT screening especially integrated with comprehensive tobacco cessation is a remarkable potent tool for improving health of tobacco-exposed individuals but especially impactful with women. Differences in gender will be discussed regarding lung cancer in never smokers, susceptibility to cigarette smoke, lung cancer development, and response to screening and treatment. Future directions in lung cancer research and screening will be reviewed.
- Understand the global burden of lung cancer in women and how it differs from males
- Discuss the importance of lung cancer screening in the female population to detect lung cancer earlier when it's more easily treated with significant improved survival
- Describe treatment for lung cancer in women and gender differences in response and survival
- Provide an overview for future directions regarding lung cancer screening and research
Moderator: James L. Mulshine, MD
Professor, Chair, Screening and Early Detection Committee, IASLC, Rush University, Chicago.
Mary Pasquinelli, DNP, FNP-BC: Presenting: The Global Burden of Lung Cancer in Women, What Do we Know?
Adjunct Clinical Instructor - UIC College of Nursing, Director, Lung Cancer Screening Program, Advanced Practice Nurse, Pulmonary and Medical Oncology, University of Illinois Hospital & Health Science System (UI Health).
Claudia I. Henschke, PhD, MD
Presenting: Lung Screening for Women - Susceptibility and Cure Rates Professor
Department of Radiology, Director, Early Lung and Cardiac Program, The Icahn School of Medicine at Mount Sinai, New York, NY.
Andrea S. Wolf, MD, MPH
Presenting: Treatment of Lung Cancer: Does Gender Matter?
Associate Professor, Director, New York Mesothelioma Program, Department of Thoracic Surgery, The Icahn School of Medicine at Mount Sinai, New York, NY.
For any inquiries, please contact meetings@iaslc.org.
- Understand the global burden of lung cancer in women and how it differs from males
- Discuss the importance of lung cancer screening in the female population to detect lung cancer earlier when it's more easily treated with significant improved survival
- Describe treatment for lung cancer in women and gender differences in response and survival
- Provide an overview for future directions regarding lung cancer screening and research
Moderator: James L. Mulshine, MD
Professor, Chair, Screening and Early Detection Committee, IASLC, Rush University, Chicago.
Mary Pasquinelli, DNP, FNP-BC: Presenting: The Global Burden of Lung Cancer in Women, What Do we Know?
Adjunct Clinical Instructor - UIC College of Nursing, Director, Lung Cancer Screening Program, Advanced Practice Nurse, Pulmonary and Medical Oncology, University of Illinois Hospital & Health Science System (UI Health).
Claudia I. Henschke, PhD, MD
Presenting: Lung Screening for Women - Susceptibility and Cure Rates Professor
Department of Radiology, Director, Early Lung and Cardiac Program, The Icahn School of Medicine at Mount Sinai, New York, NY.
Andrea S. Wolf, MD, MPH
Presenting: Treatment of Lung Cancer: Does Gender Matter?
Associate Professor, Director, New York Mesothelioma Program, Department of Thoracic Surgery, The Icahn School of Medicine at Mount Sinai, New York, NY.
For any inquiries, please contact meetings@iaslc.org.